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ABSTRACT The role of acidic pH in the conversion of human prion protein to the pathogenic isoform is investigated by means
of molecular dynamics simulations, focusing the attention on the effect of protonation of histidine residues on the conformational
behavior of human PrPC globular domain. Our simulations reveal a signiﬁcant loss of a-helix content under mildly acidic condi-
tions, due to destructuration of the C-terminal part of HB (thus suggesting a possible involvement of HB into the conforma-
tional transition leading to the pathogenic isoform) and a transient lengthening of the native b-sheet. Protonation of His-187
and His-155 seems to be crucial for the onset of the conformational rearrangement. This ﬁnding can be related to the existence
of a pathogenic mutation, H187R, which is associated with GSS syndrome. Finally, the relevance of our results for the location
of a Cu21-binding pocket in the C-terminal part of the prion is discussed.
INTRODUCTION
According to the ‘‘Protein only hypothesis’’ (Grifﬁth, 1967;
Prusiner, 1991), the misfolded isoform (PrPSc) of the normal
cellular prion protein (PrPC) is recognized as the pathogenic
agent responsible for the transmissible spongiform encepha-
lopathies, a class of neurodegenerative diseases including
scrapie in sheep; bovine spongiform encephalopathy in
cattle; and Kuru, CJ Disease, GSS syndrome, and FFI in
humans (Prusiner and DeArmond, 1994; Weissmann, 1996).
A key event in prion disease pathology appears to be the
conformational transition of PrPC to PrPSc. PrPSc is
insoluble, partly protease resistant, and its N-terminally
truncated form polymerizes into amyloid ﬁbrils (Prusiner
et al., 1983; Prusiner, 1991). PrPC and PrPSc are chemically
indistinguishable (Stahl et al., 1993) but their secondary,
tertiary, and quaternary structures differ (Caughey et al.,
1991; Stahl and Prusiner, 1991; Pan et al., 1993). PrPC
structure (resolved by means of NMR spectroscopy (Riek
et al., 1996, 1997; Donne et al., 1997; Lopez Garcia et al.,
2000; Zahn et al., 2000) and more recently by x-ray
crystallography (Knaus et al., 2001; Haire et al., 2004))
consists of an unstructured N-terminal region (21–124 aa),
a structured core (125–228 aa) including three a-helices
(HA, HB, HC spanning residues 144–154, 173–194, and
200–228, respectively for huPrPC), and a short antiparallel
b-sheet (formed by two strands, S1 and S2, comprising
residues 128–131 and 161–164, respectively, for huPrPC). A
stable disulﬁde bridge connects HB to HC, and there are two
glycosylation sites at Asn-181 and Asn-197. The N-terminal
region contains an octarepeat (PHGGGWGQ) that has a high
afﬁnity for copper ions (Cu21) (Hornshaw et al., 1995;
Sto¨ckel et al., 1998); so it has been hypothesized that PrPC is
involved in copper metabolism (Pauly and Harris, 1998).
PrPSc is more difﬁcult to characterize because of its
insolubility and tendency to aggregate. According to circular
dichroism and Fourier transform infrared spectroscopic
studies, PrPSc has a dramatically higher (43% vs. 3%)
b-sheet and lower (30% vs. 42%) a-helix content with re-
spect to PrPC (Pan et al., 1993; Safar et al., 1993). However
the precise nature of the key event triggering the conforma-
tional transition and the detailed structure of PrPSc are still
unknown. Some experimental studies (Gorodinsky and
Harris, 1995; Taraboulos et al., 1995; Harris, 2001) indicate
that the conversion to the scrapie isoform may occur on the
cell surface. On the other hand, the accumulation of PrPSc in
endosomes of scrapie-infected cells with prevalent acidic pH
values (4.0–6.0) (Lee et al., 1996) has suggested that acidic
pH could trigger PrPC conformational transition to PrPSc
(Hornemann and Glockshuber, 1998; Kelly, 1998).
In particular, recent experimental works show that acidic
conditions and the presence of a denaturant (urea, guanidine
hydrochloride) drive both human PrP(90–231) and murine
PrP(121–233) toward a b-sheet rich intermediate, thus
highlighting that pH-dependence is an intrinsic property of
the C-terminal domain (Swietnicki et al., 1997; Jackson et al.,
1999; Hornemann and Glockshuber, 1998). Mildly acidic
pH conditions (4.4–6.0) in absence of a denaturant induce
a conformational transition of huPrP(90–231) leading to
exposure of hydrophobic residues (Swietnicki et al., 1997).
The effect of strongly acidic conditions (glutamic acid,
aspartic acid, lysine, arginine, and histidine residues pro-
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tonated) on prion conformation has also been recently
investigated by molecular dynamics simulations (Alonso
et al., 2001, 2002; Sekijima et al., 2003). Daggett and
colleagues (Alonso et al., 2001, 2002) studied Syrian
hamster, human, and mouse prion proteins, using models
including the N-terminal region (107–125 aa), and found that
at low pH the protein exhibits a higher conformational
mobility and the sheet-like structure increases both by
lengthening of the native b-sheet and by addition of a portion
of the N-terminus to widen the sheet by two additional
strands. Both experimental and computational results thus
suggest that a low pH can play a relevant role in modulating
the conformational transition to the scrapie isoform.
We further investigate this hypothesis in this study,
checking how human PrPC globular domain reacts to mildly
acidic conditions, i.e., much less acidic than that investigated
by Alonso et al. (Alonso et al., 2001, 2002) and Sekijima
et al. (2003), in which protonation should involve mainly
histidine residues. We tackle this goal by means of molecular
dynamic (MD) simulations (van Gunsteren and Berendsen,
1990; Braatz et al., 1992; Fox and Kollman, 1996), which
have already been fruitfully used to investigate the dy-
namical behavior of prion proteins (Zuegg and Gready,
1999; Billeter and Wu¨thrich, 2000; Parchment and Essex,
2000; Alonso et al., 2001, 2002; DeMarco and Daggett,
2004; Santini and Derreumaux, 2004).
In particular, we present the results of several 10 ns MD
simulations of the structured core (125–228 aa) of human
prion protein in neutral/slightly basic (hereafter PrPN) and in
mildly acidic (hereafter PrPH) conditions. In PrPN lysine and
arginine are positively charged, glutamic acid and aspartic
acid negatively charged, and the four histidines neutral,
whereas in PrPH all the histidines are positively charged, but
glutamic acid and aspartic acid remain unprotonated. We
decided to focus our attention exclusively on histidine
residues because human PrP(90–231) exhibits a conforma-
tional change which is complete at pH 4.4 but starts at pH 5.5
(Swietnicki et al., 1997). At that pH it is possible that all the
histidine residues are protonated, whereas the same assump-
tion cannot be made for glutamic acid and aspartic acid,
whose pK is ;4.3 and ;3.9, respectively, and can be easily
decreased by several units (for example, when glutamic acid
and aspartic acid are engaged in salt bridges with positively
charged residues). It is thus probable that there is a pH range
where all histidines are positively charged, whereas most, if
not all, of the glutamic acid and aspartic acid residues are still
negatively charged. On the other hand, from an experimental
point of view, a direct correspondence between histidine
protonation state and prion protein conformation is still
lacking. As a matter of fact, both NMR and x-ray studies on
PrPC were unable to assess the protonation state of histidine
residues. So, our MD simulations could be useful to evalu-
ate the effect of histidine protonation in determining the
conformational behavior of human prion protein globular
domain. Furthermore, histidines can potentially act as metal
coordination sites. Although the presence of copper binding
sites beyond the structured core of the protein has been
questioned (Burns et al., 2003;), several experimental studies
(Cereghetti et al., 2001, 2003; Van Doorslaer et al., 2001)
show that the C-ter part of the protein can effectively bind
Cu21 ions, and it has been suggested that one of the binding
sites contains a histidine residue. However, from an experi-
mental point of view, the precise location of these metal
binding sites and the consequence of the metal binding on
the prion conformation are still unknown. Binding of a metal
cation is obviously a much more complex chemical process
than simple protonation (for example it involves more than
one residue). Nonetheless, exploring how the protein reacts
to the presence of a positive charge in the proximity of
a histidine residue could give useful hints on some of the
possible effects of metal cation coordination too. Finally,
His-187 is involved into a pathogenic mutation associated
with GSS syndrome (H187R) (Cervenakova et al., 1999),
which implies a positively charged residue in position 187,
analogously to His-187 protonation.
Since MD simulations are much more reliable when based
on accurate experimental structures, we choose to performour
study on the structured part of the prion, the only one for
which unambiguous structural data are available. The exclu-
sion of the 90–124 unstructured N-terminal region avoids
errors due to an arbitrary guess for this fragment. This choice,
even if preventing us from obtaining relevant conformational
changes due to rearrangement of the more ﬂexible N-terminal
fragment, should put on a ﬁrmer ground all the conclusions
drawn from the analysis of our computational results.
Furthermore, the structured core of PrPC, even if not infec-
tious, well represents the characteristic behavior of the full-
length prion protein exhibiting an intrinsic pH-dependence
and an afﬁnity for metal cations.
METHOD
Both PrPN and PrPH MD simulations started from the NMR structure (Zahn
et al., 2000) of human PrP(125–228) (PDB entry 1QLX), determined in
mildly acidic conditions (pH¼ 4.5). As mentioned above, in PrPN lysine and
arginine are positively charged, glutamic acid and aspartic acid negatively
charged, and all histidines are neutral, whereas in PrPH all histidines were
positively charged, but glutamic acid and aspartic acid remain unprotonated.
In both systems the disulphide bond was left intact, as experimental
evidences indicate it should be necessary for infectivity (Somerville et al.,
1980; Turk et al., 1988; Hermann and Caughey, 1998). Simulations were
performed at constant temperature within a ﬁxed-volume box ﬁlled with
SPC (Berendsen et al., 1981) water molecules by using periodic boundary
conditions. The net charges of PrPN and PrPH were compensated by adding
three Na1 and one Cl ions, respectively. PrPN simulation includes 20,117
atoms and the PrPH one 20,843 atoms. The temperature was kept constant
at 300 K using the isothermal Gaussian temperature coupling (Brown and
Clarke, 1984). LINCS (Hess et al., 1997) was used to constrain bond
lengths, allowing a time step of 2 fs. The particle mesh Ewald method (PME)
(Darden et al., 1993, 1999) (grid spacing of 0.12 nm) was used for
electrostatic calculations, thus properly accounting for long-range inter-
actions. A nonbonded cutoff of 0.9 nm for Lennard-Jones potential was
used. For both systems the solvent was relaxed by energy minimization,
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followed by 15 ps of MD at 300K, while restraining protein atomic positions
with a harmonic potential. The systems were then minimized without
restraints and their temperature brought to 300 K in a stepwise manner: 15-
ps-long MD runs were carried out at 50, 100, 200, 250, and 300 K before the
production runs were started at 300 K. Subsequently both systems were
simulated for 10 ns with constrained roto-translational motions (Amadei
et al., 2000). Both simulations were performed with the GROMACS
simulation package (van der Spoel et al., 1995). A modiﬁcation of
GROMOS87 force ﬁeld (van Gunsteren and Berendsen, 1987; van Buuren
et al., 1993; van Gunsteren et al., 1996), widely and successfully applied to
the study of different classes of proteins (de Groot et al., 1998; Grottesi et al.,
2002), was used. Although a comparison between different force ﬁelds is
outside the scope of this study, we point out that recent studies devoted to
this aspect indicate that most force ﬁelds (including GROMOS96 based on
GROMOS87), although providing quite different quantitative results,
behave comparably concerning general trends, thus providing a coherent
picture of the overall behavior of the system under study (Hu et al., 2003;
Mu et al., 2003). Moreover, the force ﬁeld we have used is widely used by
the scientiﬁc community and several recent studies convincingly show that
it delivers reliable results for a number of biological systems, includ-
ing peptides and proteins. In the particularly difﬁcult ﬁeld of folding
simulations, the GROMOS96 code (based on the GROMOS87 force ﬁeld)
has provided remarkable results for b-peptides (Daura et al., 1997, 1998,
1999). Secondary structure elements were assigned by the DSSP program
(Kabsch and Sander, 1983), whereas INSIGHTII (Accelrys) and MOLMOL
(Koradi et al., 1996) programs were used for model manipulation, visual
analysis and ﬁgure production.
RESULTS
In the following we will use the standard labels HA, HB, HC,
and S1, S2 to indicate the three a-helices and the two strands
of the b-sheet, respectively. Regions connecting these sec-
ondary structure elements (S1, HA, S2, HB, HC) will be
referred to as tA, tB, tC, and tD, respectively (see Fig. 1).
Inspection of Fig. 2 reveals that PrPN is stable during
the free dynamic run. The Ca root mean-square deviation
(RMSD) increases rapidly within 0.5 ns and then it remains
stable at 0.18 nm over the whole simulation period (see
Fig. 2). The positions and lengths of the different second-
ary structure elements of PrPN are well preserved during
the simulation (see Fig. 3) and similar to the initial
NMR structure. This result is in agreement with previous
MD studies, thus conﬁrming the reliability of the adopted
computational protocol. HA, HB, and HC span residues
144–152, 172–194, and 200–226, respectively, whereas S1
and S2 include, on average, residues 129–131 and 161–163,
respectively.
On the other hand, protonation of the four histidine
residues gives rise to signiﬁcant conformational changes. As
a matter of fact, PrPH shows a major rearrangement with re-
spect to the starting structure reaching a constant RMSD of
0.28 nm after 6 ns of simulation (see Fig. 2).
An analysis of the secondary structure indicates that HA
(residues 144–152) and HC (residues 200–228) are stable
throughout the simulation, whereas the C-terminal part
(residues 187–194) of HB is highly unstable, undergoing
a progressive destructuration during the simulation. In
particular, HB loses seven residues, reaching after ;7 ns an
equilibrium length spanning residues 172–187, whereas
fragment 192–197 exhibits a stable bend structure during
the second half of the simulation. Moreover the b-sheet
content increases, reaching nine residues during the 4.3–6.1 ns
time interval and ﬂuctuating around four to six residues for the
remaining simulation time.
The ﬁnal structures issuing from both simulations are
shown in Fig. 1. The key events underlying the conforma-
tional behavior of PrPH are the breaking of the salt bridge
between Arg-156 and Glu-196 and the competition between
the strongly attractive interactions His-155–Glu-196 and
His-187–Glu-196.
During the early stages of the simulation the salt bridge
between Arg-156 and Glu-196, present in PrPN trajectory
and recognized as one of the most signiﬁcant interactions for
the stability of the protein by NMR and MD works (Zuegg
and Gready, 1999), breaks whereas Glu-196 is engaged into
a new salt bridge with His-155. This last salt bridge is stable
during the ﬁrst 6 ns of the simulation (see Fig. 4).
The side chain of His-187 disrupts its hydrogen bond with
the carboxylic group of Arg-156, which was stable in PrPN
FIGURE 1 Final structures of PrPN (left) and PrPH (right) runs. Labels
used to indicate secondary structure elements and connecting regions are
also shown. Histidine residues (140, 155, 177, 187) are displayed in sticks.
FIGURE 2 Root mean-square deviation of the Ca carbon atoms positions
from their positions in the starting NMR structure as a function of time in the
PrPN (dashed line) and PrPH (solid line) runs.
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trajectory, and shifts away from the cleft between tB and tD.
The His-187 shift is likely responsible for the reorientation of
the positively charged N-terminal region (125–127) of the
protein (see Fig. 1). This region is indeed directed toward the
C-terminus of HB in the NMR structure, as well as in the
whole PrPN simulation. On the contrary, during the ﬁrst 2 ns
of PrPH simulation it progressively turns to the opposite
direction, i.e., toward the N-terminus of HB. This reorienta-
tion, that decreases the charge repulsion with His-187, gives
rise to a new hydrogen bond between Gly-126 and Pro-165,
which is compatible with an elongation of the b-sheet.
The overall PrPH simulation is governed by the pro-
gressive approach of His-187 and Glu-196. However, as
mentioned above, during the ﬁrst half of the simulation the
His-155–Glu-196 salt-bridge never breaks (Fig. 4) so that the
global process is the approach of three residues (His-187–
Glu-196–His-155) which ends up in the formation of
a pocket stable between 4.3 and 6.0 ns. It is noteworthy
that the pocket formation (4.3–6.0 ns) occurs contemporarily
to b-sheet elongation (4.2–6.1 ns), through the formation of
the hydrogen bond between Ser-132 and Val-161. This latter
interaction, that has never been previously reported, appears
to play a fundamental role in lengthening and stabilizing the
b-sheet between S1 and S2.
Our analysis also reveals the important role played by side
chain/main chain interactions in preventing/favoring b-sheet
elongation. During b-sheet lengthening, in fact, there is a
breaking of the interactions of the side chains of Gln-160 and
Asn-159 with the carboxylic group of Gly-131 and Met-134,
respectively. On the other hand, between 4.2 and 6.1 ns the
carboxylic group of Ser-132 stably binds to Val-161 amidic
group, whereas in the remaining time of the simulation (as
well as in PrPN simulation), it strongly interacts with the side
chain ofArg-220. Theb-sheet lengthening is accompanied by
small conformational rearrangements in the whole protein,
leading to the formation of new interactions, like e.g., that
between Gln-160 and Gln-186.
After 6 ns His-155 breaks its hydrogen bond with Glu-
196, whereas Glu-196 remains strongly bound to His-187 for
the remaining simulation time. Almost simultaneously, (see
Fig. 4) the Ser-132–Val-161 hydrogen bond breaks up, de-
creasing the b-sheet length. However, it is worth noting that
the conformation of several residues (Gly-131, Ser-132, Ala-
133) is more extended in PrPH than in PrPN for the whole
simulation time, making easier transient elongations of the
b-sheet made by S1 and S2. In particular, a longer b-sheet
is again stable between 9 and 9.5 ns (see Fig. 3). The
destructuration process of HB goes on until 7 ns, and in the
last 3 ns of the simulation PrPH does not undergo any
signiﬁcant conformational transition. As we have seen,
protonation of His-155 and His-187 seems to play a key role
in the conformational transition of PrPH. Our results suggest
instead that this is not the case for His-140 and His-177: in
both PrPN and PrPH His-140 is stably involved in a salt-
bridge with Asp-147, whereas His-177 is always well ex-
FIGURE 3 Secondary structure of PrPN (up-
per panel) and PrPH (lower panel) as a function
of time, determined with DSSP.
FIGURE 4 Side chains minimum distance between His155 and Glu-196
(black) and between His-187 and Glu-196 (shaded line) as a function of time
in PrPH trajectory. Distance between Ser-132 carboxylic and Val-161 amidic
groups is also shown (light shaded line).
3626 Langella et al.
Biophysical Journal 87(6) 3623–3632
posed to the solvent and doesn’t seem to affect the overall
spatial arrangement of the protein. Furthermore, it is in-
teresting to highlight that, although the NMR experimental
structure is more similar to the PrPN average structure, some
local details seem to be better modeled by PrPH. For example
the hydrogen bonds pattern of the region linking tA to HA is
characterized by Asp-147–His-140 and Asp-147–Phe-141
hydrogen bonds by both NMR experiments (Zahn et al.,
2000) and PrPH simulation. In PrPN simulation a third stable
hydrogen bond is found between Asp-147 and Gly-142. As a
consequence, the local conformation of that region (encom-
passing His-140) is more similar to the NMR structure in
PrPH than in PrPN. Those results suggest that His-140 and
His-177 might be protonated under NMR experimental
conditions.
RESULTS VALIDATION
Since the conformational features exhibited by the PrPN
system during the simulation run are in agreement with both
previous experimental (Zahn et al., 2000) and computational
(Zuegg and Gready, 1999; Okimoto et al., 2002) studies, we
have focused our attention on assessing the statistical sig-
niﬁcance of the PrPH simulation and the convergence of the
results. To that aim we have performed two other indepen-
dent 11.4-ns-long test simulations (test1 and test2) differing
from PrPH simulation (hereafter Ref
H) in the starting protein
conﬁguration used and in the random seed scheme for
velocities attribution employed.
In test1 velocities were redistributed at the beginning of
the free-dynamics, whereas in test2 they were redistributed
every 700 ps during the free-dynamics. The new starting
conﬁguration has been chosen among a set of 20 human
prion protein NMR structures (pdb code: 1QLZ) and is the
one (model 8) with the highest Ca root mean-square
deviation (0.991 A˚) with respect to the representative
structure (1QLX.pdb) used as starting conﬁguration in RefH.
The dynamic picture issuing from test1 and test2 is very
similar to that of RefH. Both simulations reveal indeed that
the system undergoes a signiﬁcant rearrangement (RMSD 
3.0 A˚) with respect to the starting conﬁguration, the main
event being the progressive HB C-terminal end destructura-
tion (see Fig. 5).
Both simulations are governed by the same interactions
previously detected in RefH: Glu-198 makes a stable salt-
bridge with His-155 thus disrupting the stabilizing in-
teraction with Arg-156; His-187 progressively approaches
Glu-196 thus forming a new stable salt-bridge (see Fig. 6).
In test1 those conformational transitions occur with a delay
of;4 ns with respect to RefH (and for this reason we slightly
increased the simulation time up to 11.4 ns). However, this
result is not surprising, due to the different starting model
used, and it is meaningful that, apart the aforementioned
delay, test1 and RefH run almost parallel. The only
noticeable difference between test2 and RefH is instead
a longer persistence of the three center salt-bridge between
His-155, His-187, and Glu-198, but this result can also be
explained on the basis of the different velocities redistribu-
tion scheme used in test2. The agreement between the results
of the three simulations performed supports the reliability of
our conclusion and puts on a ﬁrmer ground all the following
considerations.
DISCUSSION AND CONCLUSIONS
In this study we have shown that protonation of the four
histidine residues decreases the conformational stability of
human PrP(125-228), leading to a signiﬁcant structural re-
arrangement (RMSD 3.0 A˚) with respect to the starting
structure, which involves a decrease in the a-helix and
FIGURE 5 Secondary structure of test1 (up-
per panel) and test2 (lower panel) as a function
of time, determined with DSSP.
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a transient increase in the b-sheet content. This result is
consistent with the experimental ﬁnding that murine
PrP(121–231) (Hornemann and Glockshuber, 1998) confor-
mation exhibits a signiﬁcant dependence on pH and human
PrP(90–231) undergoes a conformational rearrangement
under mildly acidic conditions (pH 4.4–6.0) eventually
losing a-helical content upon further pH lowering (Swiet-
nicki et al., 1997).
The most relevant structural changes involve the destruc-
turation of the C-terminal part of helix B (residues 188–194).
Until now it has instead been assumed that HB and HC
constitute the stable core of the protein whereas the
conformational transition to the b-rich form involves helix
A (Parchment and Essex, 2000; Alonso et al., 2001).
However the results of our computations are in line with
NMR (Donne et al. 1997; Zahn et al., 2000) and x-ray
(Knaus et al., 2001) data revealing a signiﬁcant ﬂexibility
of the C-terminal end of HB, with a very recent sequence
alignment study predicting that the C-terminal residues in
HB are frustrated in their helical state (Dima and Thirumalai,
2002), and also with MD simulations by Santini and
Derreumaux (2004) which shows that unfolding of HA is
not an early step in PrP interconversion and that there is no
evidence that HB and HC are more stable than HA. Other
recent studies further support the involvement of HB in the
conformation transition to the b-rich prion isoform (Gilis and
Rooman, 2000; Karlberg et al. 2001; Mornon et al., 2002).
This behavior can be relevant also for the development of
the infection, since this region belongs to the mini-prion
(Muramoto et al., 1996).
Another interesting feature is the transient elongation of
the native b-sheet due to the newly formed hydrogen bond
between Ser-132 carboxylic and Val-161 amidic groups and
likely enhanced by N-terminus reorientation. So, native
b-sheet behaves like a nucleation site for a further increase
of the b-sheet content, as has been hypothesized in other
experimental and computational works (Cohen and Prusiner,
1998; Alonso et al., 2001).
A comparison between our results and those of previous
computational studies by Alonso and Daggett is made
difﬁcult by the different system they examined (residues
109–228, instead of 125–228) and, especially, by the very
different conditions under which the two studies have been
performed. Extremely strong acid conditions, involving the
protonation of all glutamic acid and aspartic acid residues lead
to a breaking of all the salt bridges of the protein and increase
its total positive charge up to 17. Such a system is obviously
very different from that we have investigated: just to make an
example, the Glu-196–His-187 salt bridge (vide infra) would
not be possible if Glu-196 is protonated. Anyway we have
performed a test MD simulation (15-ns long) of huPrP(125–
228) under strongly acidic conditions (glutamic acid, aspartic
acid, and histidine protonated) which did not show any
signiﬁcant conformational rearrangement. Indeed, the aver-
age Ca RMSD during the last 5 ns was 2.5 A˚ and the
secondary structure elements are retained during the whole
simulation (see Fig. 1 in supplementary material). These
results agree with the MD study performed on huPrP(125–
228) by Sekijima et al. (2003), which does not show any
dramatic conformational rearrangement under strongly acidic
pH conditions. On the other hand these results are not in
contrast withAlonso andDaggett ones. As amatter of fact, the
work of Alonso and Daggett on huPrP(109–228) shows that
the main changes, leading to addition of a portion of the
N-terminus to the native b-sheet and to native b-sheet
elongation, happen in and are driven by the N-terminal tail
(109–124) which is not included in our model as well as in the
study by Sekijima et al. (2003).
A detailed analysis of the behavior of the four histidine
residues during the simulations reveals that the protonation
of His-155 and His-187 is critical for the onset of the con-
formational transition. In particular the key event leading to
the destructuration process of the C-terminal end of HB is the
presence of a positive charge on His-187, providing the
driving force for the formation of salt bridge with the Glu-
196 side chain. This is a crucial point: His-187 is indeed
involved in a pathogenic mutation associated with GSS
syndrome in human, H187R (Cervenakova et al., 1999),
which implies the presence of a positive charge in position
187. Our computational results thus allow us to put forward
an explanation for the destabilizing effect of the H187R
mutation on the PrPC folding. Intriguingly, there is another
well-known pathogenic mutation which places a positive
charge in the C-terminus of HB, T188R/K, thus conﬁrming
the destabilizing effect of positive charges in that region. On
the other hand, His-155 is essential for the breaking of the
stabilizing salt bridge between Arg-156 and Glu-196, just in
the early stages of the simulation.
A comparison among PrPN and PrPH MD simulations and
experimental NMR data prompt us to suggest that His-140
FIGURE 6 Side chains minimum distance between His-155 and Glu-196
(black line) and between His-187 and Glu-196 (gray line) as a function of
time in test1 (upper panel) and test2 (lower panel) runs.
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and His-177 could be protonated, whereas His-155 and His-
187 are neutral under NMR experimental conditions. The
more acidic behavior of His-155 and His-187 is qualitatively
supported by MEAD computations (pH titrations curves
were calculated on the NMR experimental structures by
using the MEAD suite (Bashford et al., 1992) and the
XMCTI program (Beroza et al., 1991). In MEAD calcu-
lations dielectric constants 4.0 and 80.0 for the protein and
the solvent, respectively, were used. Atomic radii and partial
charges were taken from the PARSE library distributed in
MEAD. The individual intrinsic pKa values and the interac-
tion matrix produced by MEAD were input to XCMTI
(which uses a Monte Carlo procedure to average over all
possible titration microstates of the protein and to calculate
the titration curves), predicting that His-140 and His-177
should have pKa $7, whereas His-155 and His-187 should
be protonated only for pH ,5. At this pH values it could be
obviously possible that other protonable residues as aspartic
acid and glutamic acid undergo protonation; however our
MEAD calculations suggest that the only residues having
pKs close to ﬁve are located at the C-ter of Helix C, i.e., in
a region not involved in the most signiﬁcant conformational
transition of PrPH. Furthermore, according to our simulations
the only acid residue whose protonation is expected to inﬂu-
ence our results is Glu-196. However, our study, in agree-
ment with previous experimental and computational studies
(Zuegg and Gready, 1999), shows that before His-187 pro-
tonation this residue should be salt-bridged with Arg-156,
and thus its pKa is expected to be signiﬁcantly ,4.5.
Our simulations could also be useful to corroborate the
results of a very recent electron paramagnetic resonance
(EPR) study of ad hoc designed murine prion mutants
strongly suggesting that His-187 is involved in one of the
copper binding sites of PrPC (Cereghetti et al., 2001, 2003;
Van Doorslaer et al., 2001). However it was not possible to
determine the whole coordination site. Nonetheless, copper
binding is not predicted to give rise to substantial conforma-
tional changes. PrPH simulation shows that a conformational
transition does exist, leading three possible Cu21 ligands
(Glu-196, His-155, and His-187) to point toward the same
region, the cleft between tB and tD, that is well solvent
exposed (see Fig. 7).
Small changes in the side chain conformations could then
easily allow to accommodate a copper ion. Can the presence
of a Cu21 ion, under physiological conditions, be the driving
force for a conformational change like the one caused by
histidine protonation? Only calculations performed in the
presence of Cu21 ion could obviously give a deﬁnite answer
to the above question. However our results suggest what con-
formational transition allows His-187 to be approached by
additional ligands without dramatic changes in the overall
conformation of the prion, apart from some partial unfolding
of the C-ter part of Helix B.
According to our simulation, His-187 and Glu-196 are
thus the most probable candidates for being the binding
residues of Cu21, but it cannot be excluded that in human
PrPC also His-155 is involved. Since murine prion protein
has only three histidine residues (His-140, His-177, and His-
187), the EPR data of Cereghetti et al. (2001, 2003) cannot
shed light on this question. Interestingly, NMR experiments
on human PrPC suggest that region 153–159, centered on
His-155, is inﬂuenced by the metal binding (Jackson, et al.
2001). A comparative EPR analysis of copper binding to the
C-terminal domain of human PrPC would therefore be very
interesting: eventually, the discovery of different, species-
dependent, speciﬁc metal-prion complexes could have
signiﬁcant implications for a better understanding of prion
deseases species barrier.
The possible involvement of His-187 in the metal binding
allows to propose an alternative explanation to the path-
ogenic mutation H187R, that (besides having a role in HB
C-terminal part destructuration) could play some role in
preventing copper binding too. The existence of another
pathogenic mutation close to the region we propose as a
copper binding site, F198S, which has been experimentally
proven (Cereghetti et al., 2001, 2003; Van Doorslaer et al.,
2001) to keep copper from binding to His-187, further sup-
ports the hypothesis that PrPC pathogenic mutations could be
related to altered Cu(II) binding.
Due to the complexity of the phenomena under study, it
is not easy to assess the relevance of our results for
characterizing the structure of the experimentally detected
unfolding intermediate of PrPC (Apetri and Surewicz, 2002),
and, more in general, the conformational transition from
PrPC to PrPSc. On one hand, we have studied the structured
part of an isolated human prion protein. Several intra-
molecular and intermolecular interactions cannot be taken
into account by our simulations, and they could be fun-
damental for the stabilization of the PrPSc. Furthermore,
our model lacks N-linked glycosylation sites which could
play a role in the conformational transition mechanism.
Finally, many different effects and kinds of interactions have
been predicted to modulate the conformational behavior of
FIGURE 7 PrPH structure at 5.5 ns. Lengthening of native b-sheet can be
observed. Residues His-155, His-187, and Glu-196 are displayed in stick.
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the prion protein: it is thus sure that the protonation of four
histidine residues, and even the decrease of the pH alone,
cannot be considered the only important effects able to
destabilize a-helical and to stabilize b-sheet structures in
prions.
On the other hand, experiments show that the prion
conformational rearrangement due to pH decrease starts
already under mildly acid conditions, suggesting that
histidine can play a relevant role in this phenomenon. Our
study points out that this is the case: the simple protonation of
the histidine residues might trigger a conformational transi-
tion involving a signiﬁcant decrease of a-helical content and
the stabilization of extended structures. The analysis of the
MD results, showing that the protonation of two histidine
residues (His-187 and His-155) could be the main cause of
this transition, not only provides insights on some key
microscopic events giving account of the pH inﬂuence on
prion conformation, but suggests which are the ‘‘intrinsic’’
instability lines of the protein. The region comprising the
C-ter part of HA and HB, tB and tD is predicted to be ex-
tremely sensitive to the presence of extra-positive charges,
and conformational rearrangements in that region (e.g., the
formation of the transient pocket depicted in Fig. 7) can
propagate through the protein leading to the b-sheet
lengthening. From this point of view, it could be signiﬁcant
that some important pathogenic mutations (H187R, T188R/
K, E200K, D202N) involve the appearance of positively
charged and/or the disappearance of negatively charged
residues in that region or in its proximity. The effect of those
mutations could obviously be signiﬁcant for interprotein
interactions. However, our results suggest that, even if such
mutations do not alter signiﬁcantly the thermodynamic
stability of the folded state, they could increase the stability
of unfolding intermediates with a decreased a-helical content
and longer andmore stableb-sheet, which constitute themain
structural differences between PrPC and PrPSc.
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